New Results From HEALEY ALS Platform Trial Show Promise for Treating ALS

MONTREAL, Oct. 17, 2023 /PRNewswire/ — One of the central challenges of Amyotrophic Lateral Sclerosis ALS research is finding ways to slow the progression of the relentlessly degenerative brain disease. Recently, based on results of the HEALEY ALS Platform Trial, two experimental medications plan to move to phase 3 clinical trials. This means the drugs … Read more